InvestorsHub Logo
Followers 188
Posts 28606
Boards Moderated 1
Alias Born 08/29/2012

Re: NASDAQ2020 post# 235584

Wednesday, 12/07/2016 9:47:35 PM

Wednesday, December 07, 2016 9:47:35 PM

Post# of 399511
Elite's unique, innovative , market disruptive 2 bead ADF opiod/naltrexone ADFormulation has been validated by FDA for use with ALL Immediate and Extended Release Opiods.

"the FDA made no comment about Elite’s technology because it works and it’s solid. They made no comment on the human abuse liability studies because again they were solid and they work; or with the withdrawal study or the efficacy study – the Bunionectomy. This is great news for Elite’s ADT platform. There is no effect on Elite’s ER formulations "

You Can Tell A Man's Character By The Way He Treats Those Who Can Do Nothing For Him

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News